CHOC currently has two Institutional Review Boards (IRBs):
- The Industry-Track IRB
- The In-house IRB
The Industry-Track and the In-House IRBs are bound by the same federal and institutional regulatory guidelines, but each carries the responsibility for the review of a different type of study.
The Industry-Track IRB meets the 1st and 3rd Monday of each month and reviews human subject research that is sponsored by pharmaceutical companies, contract research organizations or other for-profit organizations. IRB fees are charged for review by this committee.
The In-house IRB meets on the 2nd Monday of each month. This IRB is responsible for reviewing studies that involve human subjects and that are investigator-initiated* and funded by CHOC and/or other organizations, as well as human subjects research that is funded by government or non-profit organizations.
*Investigator-initiated studies that are being funded by an industry sponsor and have received prior scientific review will be considered on a case by case basis to determine if they require review by the In-house or Industry Track committee.
If you need assistance determining which committee should review your study please contact the IRB Office.
General IRB Information:
FWA and IRB Numbers:
In-house IRB: IRB00001166
Industry Track IRB: IRB00001182
Federalwide Assurance: FWA00000255
This information is also listed on the OHRP web page at http://ohrp.cit.nih.gov/search/asearch.asp#ASUR
CHOC Institutional Review Board – Research Institute
1201 West La Veta, Research Building, 4th Floor, Room 410
Orange, CA 92868
Phone: (714) 509-8869
Fax: (714) 509-3909
CITI Human Subjects Training
Office of Human Research Protections (OHRP)
Food and Drug Administration
Children in Research Link